Literature DB >> 8574828

Detection of human immunodeficiency virus type 1-specific memory cytotoxic T lymphocytes in freshly donated and frozen-thawed peripheral blood mononuclear cells.

X L Huang1, Z Fan, J Liebmann, C Rinaldo.   

Abstract

Loss of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte (CTLm) responses is associated with disease progression in HIV-1 infection. In this study, nonspecific stimulation of peripheral blood mononuclear cells (PBMC) from HIV-1-infected homosexual men with anti-CD3 monoclonal antibody (MAb) was compared with antigen-specific stimulation with inactivated, autologous B lymphoblastoid cells (B-LCL) infected with a vaccinia virus vector encoding HIV-1 IIIb Gag, Pol, and Env (VV-GPE) for activation of HIV-1-specific CTLm responses in a bulk lysis assay and by precursor frequency analysis. The results show that VV-GPE-infected B-LCL stimulated on average 10-fold greater anti-HIV-1 CTLm activity, as detected in the bulk lysis assay, and 55-fold-greater CTLm precursor frequencies specific for the three HIV-1 structural proteins than did stimulation with anti-CD3 MAb. This effect was noted with both freshly donated and frozen-thawed PBMC. The lysis was mediated by CD8+ T cells and was restricted by the major histocompatibility class I complex. These data indicate that antigen-specific stimulation with VV-GPE-infected B-LCL is a highly efficient method for detection of anti-HIV-1 CTLm responses that is applicable to noncurrent prospective studies with frozen PBMC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574828      PMCID: PMC170219          DOI: 10.1128/cdli.2.6.678-684.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

1.  Receptor-stimulated death pathway is opened by antigen in mature T cells.

Authors:  J H Russell; C L White; D Y Loh; P Meleedy-Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens.

Authors:  J T Wong; R B Colvin
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

Review 3.  The evaluation of limiting dilution assays.

Authors: 
Journal:  J Immunol Methods       Date:  1982-03-12       Impact factor: 2.303

Review 4.  Limiting dilution analysis of human T cells: a useful clinical tool.

Authors:  C E Sharrock; E Kaminski; S Man
Journal:  Immunol Today       Date:  1990-08

5.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

6.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

Authors:  C Rinaldo; X L Huang; Z F Fan; M Ding; L Beltz; A Logar; D Panicali; G Mazzara; J Liebmann; M Cottrill
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.

Authors:  R A Koup; C A Pikora; K Luzuriaga; D B Brettler; E S Day; G P Mazzara; J L Sullivan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.

Authors:  J V Giorgi; H L Cheng; J B Margolick; K D Bauer; J Ferbas; M Waxdal; I Schmid; L E Hultin; A L Jackson; L Park
Journal:  Clin Immunol Immunopathol       Date:  1990-05

9.  Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.

Authors:  M Polydefkis; S Koenig; C Flexner; E Obah; K Gebo; S Chakrabarti; P L Earl; B Moss; R F Siliciano
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

10.  Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

Authors:  A Carmichael; X Jin; P Sissons; L Borysiewicz
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  7 in total

1.  CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.

Authors:  X L Huang; Z Fan; C Kalinyak; J W Mellors; C R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.

Authors:  M R Betts; J Krowka; C Santamaria; K Balsamo; F Gao; G Mulundu; C Luo; N N'Gandu; H Sheppard; B H Hahn; S Allen; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R L Glickman; J Q Yang; A Kaur; J T Dion; M J Mulligan; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories.

Authors:  K A Reimann; M Chernoff; C L Wilkening; C E Nickerson; A L Landay
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

5.  A semiquantitative assay for CD8+ T-cell-mediated suppression of human immunodeficiency virus type 1 infection.

Authors:  Y Chen; C Rinaldo; P Gupta
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

6.  Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.

Authors:  C R Rinaldo; X L Huang; Z Fan; J B Margolick; L Borowski; A Hoji; C Kalinyak; D K McMahon; S A Riddler; W H Hildebrand; R B Day; J W Mellors
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.

Authors:  Bernard J C Macatangay; Lu Zheng; Charles R Rinaldo; Alan L Landay; Richard B Pollard; Savita Pahwa; Michael M Lederman; R Pat Bucy
Journal:  Clin Vaccine Immunol       Date:  2010-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.